Kivu Ebola epidemic

Kivu Ebola epidemic
Name	Kivu Ebola epidemic
Location	North Kivu Province, South Kivu
Dates	2018–2020, 2021–2023
Disease	Ebola virus disease
Virus	Ebola virus (Zaire ebolavirus)
Confirmed cases	~3,500
Confirmed deaths	~2,300
Territories	Democratic Republic of the Congo

Kivu Ebola epidemic

The Kivu Ebola epidemic was a protracted outbreak of Ebola virus disease in the eastern Democratic Republic of the Congo centered in North Kivu Province and Ituri Province, with spillover into South Kivu. It intersected with active Armed conflict in Kivu (2016–present), large-scale displacement, and complex interactions among international agencies such as the World Health Organization, Médecins Sans Frontières, and the United Nations. The response involved federal and provincial authorities including the Ministry of Health (Democratic Republic of the Congo) and coordination with partners like the Centers for Disease Control and Prevention and the European Commission.

Background

The Kivu epidemic emerged in a region long affected by conflict involving armed groups such as the Allied Democratic Forces, Mai-Mai, and various Congolese Rally for Democracy offshoots, and influenced by the legacy of the Second Congo War and the First Congo War. The outbreak environment included crowded sites like Goma and Beni, international crossings at Rutshuru and Mpondwe, and humanitarian operations by organizations such as International Rescue Committee and World Food Programme. Local public health infrastructure traced roots to colonial-era institutions and post-conflict rebuilding efforts supported by donors including the World Bank and bilateral partners like United States Agency for International Development.

Outbreak Timeline

Initial cases were detected in 2018 near Mangina and Beni, prompting alerts to the World Health Organization, the African Union, and the International Health Regulations (2005). The epidemic progressed through waves marked by security incidents—attacks on treatment centers in Beni and Butembo—and major response milestones such as deployment of ring vaccination campaigns led by the Institut National de Recherche Biomedicale and partners. Case counts peaked in late 2019, with subsequent decline followed by resurgence in 2021 and localized clusters through 2023, involving notable events like transmission chains linked to funeral rites in Ituri Province and nosocomial spread in referral hospitals in Goma.

Epidemiology and Clinical Features

The epidemic was caused by the Zaire ebolavirus species, with clinical features consistent with prior outbreaks including fever, hemorrhage, gastrointestinal symptoms, and multiorgan failure observed in settings like Beni General Reference Hospital. Case fatality ratios varied across cohorts and time, influenced by access to care at treatment centers run by Médecins Sans Frontières, International Medical Corps, and the Red Cross. Transmission dynamics involved close contact during caregiving, unsafe funerary practices practiced in communities around Lake Kivu, and amplification in health-care settings similar to patterns seen in the 2014–2016 West African Ebola epidemic. Genomic sequencing by teams from Institut Pasteur and the Kabara Research Centre contributed to tracing transmission networks.

Public Health Response and Control Measures

Response measures combined surveillance, contact tracing, safe burials, and infection prevention and control implemented by actors including the Ministry of Health (Democratic Republic of the Congo), World Health Organization, Médecins Sans Frontières, United Nations Organization Stabilization Mission in the Democratic Republic of the Congo, and local civil society groups. Ring vaccination used the rVSV-ZEBOV vaccine supplied through coordination with Gavi, the Vaccine Alliance and monitored by regulatory bodies such as the Food and Drug Administration and the European Medicines Agency. Security escorts and negotiation with armed group leaders were sometimes necessary, involving actors like the United Nations and provincial governors to secure access to hotspots including Butembo and Komanda. Laboratory confirmation relied on polymerase chain reaction testing at reference laboratories such as the National Institute for Biomedical Research (DRC).

Impact on Communities and Health Systems

The epidemic strained referral hospitals in Goma and local health centers across North Kivu and Ituri, disrupting services for endemic diseases like malaria and maternal health programs supported by UNICEF and the World Bank. Displacement of populations into camps for internally displaced persons affected by clashes between groups like the Allied Democratic Forces altered demographic patterns, complicating contact tracing by teams from International Rescue Committee and Doctors Without Borders. Socioeconomic effects included reduced cross-border trade through points such as Rutshuru and impacts on mining hubs linking to actors in the Coltan supply chain. Stigmatization of survivors influenced reintegration programs run by NGOs and faith-based organizations such as Caritas Internationalis.

Research, Vaccines, and Treatments

Research efforts accelerated field trials of interventions including the rVSV-ZEBOV vaccine and monoclonal antibody treatments like ansuvimab and REGN-EB3, with clinical trial oversight by ethics committees linked to the Kinshasa School of Public Health and international partners such as the National Institutes of Health. Operational research on ring vaccination strategies involved collaboration among WHO, Gavi, the Vaccine Alliance, Wellcome Trust, and academic centers including Johns Hopkins University and London School of Hygiene & Tropical Medicine. Post-outbreak evaluations informed revisions to the International Health Regulations (2005) implementation and bolstered laboratory networks coordinated by organizations such as the African Centres for Disease Control and Prevention.

Category:Ebola virus epidemics Category:Health in the Democratic Republic of the Congo